Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
Manta K, Papakyriakopoulou P, Chountoulesi M, Diamantis DA, Spaneas D, Vakali V, Naziris N, Chatziathanasiadou MV, Andreadelis I, Moschovou K, Athanasiadou I, Dallas P, Rekkas DM, Demetzos C, Colombo G, Banella S, Javornik U, Plavec J, Mavromoustakos T, Tzakos AG, Valsami G. Manta K, et al. Mol Pharm. 2020 Nov 2;17(11):4241-4255. doi: 10.1021/acs.molpharmaceut.0c00672. Epub 2020 Oct 19. Mol Pharm. 2020. PMID: 32986435
Nasal powders of quercetin-β-cyclodextrin derivatives complexes with mannitol/lecithin microparticles for Nose-to-Brain delivery: In vitro and ex vivo evaluation.
Papakyriakopoulou P, Manta K, Kostantini C, Kikionis S, Banella S, Ioannou E, Christodoulou E, Rekkas DM, Dallas P, Vertzoni M, Valsami G, Colombo G. Papakyriakopoulou P, et al. Among authors: manta k. Int J Pharm. 2021 Sep 25;607:121016. doi: 10.1016/j.ijpharm.2021.121016. Epub 2021 Aug 16. Int J Pharm. 2021. PMID: 34411652
Comparative Serum and Brain Pharmacokinetics of Quercetin after Oral and Nasal Administration to Rats as Lyophilized Complexes with β-Cyclodextrin Derivatives and Their Blends with Mannitol/Lecithin Microparticles.
Manta K, Papakyriakopoulou P, Nikolidaki A, Balafas E, Kostomitsopoulos N, Banella S, Colombo G, Valsami G. Manta K, et al. Pharmaceutics. 2023 Jul 28;15(8):2036. doi: 10.3390/pharmaceutics15082036. Pharmaceutics. 2023. PMID: 37631250 Free PMC article.